1
|
Giovannopoulou E, Karakasi MV, Nikolaidis I, Anestakis D, Deftereos S, Blontzos N, Grigoriadis N, Pavlidis P. Congenital Supratentorial Neuroectodermal Primary Tumor: A Rare Embryonal Tumor With an Uncommon Clinical Presentation. Am J Forensic Med Pathol 2022; 43:e96-e100. [PMID: 36377857 DOI: 10.1097/paf.0000000000000775] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Eirini Giovannopoulou
- From the Department of Obstetrics & Gynaecology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki
| | | | - Ioannis Nikolaidis
- Multiple Sclerosis Center, 2nd Department of Neurology, Aristotle University of Thessaloniki - Faculty of Medicine
| | | | - Savvas Deftereos
- Department of Radiology and Diagnostic Imaging, Democritus University of Thrace-School of Medicine, Alexandroupolis
| | - Nikolaos Blontzos
- Department of Obstetrics & Gynecology, Metaxa Memorial Cancer Hospital, Attiki, Greece
| | - Nikolaos Grigoriadis
- Multiple Sclerosis Center, 2nd Department of Neurology, Aristotle University of Thessaloniki - Faculty of Medicine
| | - Pavlos Pavlidis
- Laboratory of Forensic Sciences, Democritus University of Thrace-School of Medicine, Alexandroupolis
| |
Collapse
|
2
|
Fossey M, Li H, Afzal S, Carret AS, Eisenstat DD, Fleming A, Hukin J, Hawkins C, Jabado N, Johnston D, Brown T, Larouche V, Scheinemann K, Strother D, Wilson B, Zelcer S, Huang A, Bouffet E, Lafay-Cousin L. Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. J Neurooncol 2017; 132:155-162. [PMID: 28102486 DOI: 10.1007/s11060-016-2353-0] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2016] [Accepted: 12/23/2016] [Indexed: 10/20/2022]
Abstract
While 2/3 of patients with ATRT are less than 3 years at diagnosis, the literature suggests younger children present with more aggressive disease and poorer outcome. However, little data exist on characteristics and outcome of patients diagnosed with ATRT in the first year of life. In particular, it is unclear whether they access similar treatments as do older children. We compared the cohort of patients ≤12 months from the Canadian ATRT registry to all cases extracted from the literature reported between 1996 and 2014 to describe their clinical and treatment characteristics, and potential prognostic factors. Twenty-six (33.7%) patients from the Canadian registry were ≤12 months at diagnosis as were 120 cases identified in the literature. Post-operatively, 46% of the registry's patients underwent palliation as opposed to 10.8% in the literature cohort. Palliative patients were significantly younger than those who received active therapy (3.3 vs. 6.6 months). While the use of high-dose chemotherapy (HDC) was relatively similar in both cohorts (42.9 and 35.5% respectively), radiotherapy (RT) use was significantly lower in the Canadian cohort (14.3 vs 44.9%). Children ≤6 months, who received active therapy, had a worst outcome than older ones. Gross total resection, HDC and adjuvant RT were associated with better outcomes. Eighty percent of the tested patients had evidence of germline mutation of INI1. While 1/3 of ATRT occurs within the first year of life, a large proportion only received palliative therapy. Even when actively treated, children ≤6 months fare worse. Some selected patients benefit from HDC.
Collapse
Affiliation(s)
- Mary Fossey
- Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, T3B 6A8, Canada
| | - Haocheng Li
- Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, T3B 6A8, Canada
| | - Samina Afzal
- Hematology Oncology, IWK Health Centre, 5850 University Avenue, P O Box 9700, Halifax, NS, B3K 6R8, Canada
| | - Anne-Sophie Carret
- Hematology Oncology, Centre Hospitalier Universitaire Sainte-Justine, Pavillon Charles Bruneau, A.12.39, 3175 chemin Cote Sainte-Catherine, Montreal, QC, H1T 3C5, Canada
| | - David D Eisenstat
- Pediatric Oncology, Stollery Children's Hospital, Aberhart Centre One, 11402 University Ave, Edmonton, AB, T6G 1C9, Canada
| | - Adam Fleming
- Department of Pediatrics, McMaster Children's Hospital, 1280 Main Street West, Hamilton, ON, L8S 4K1, Canada
| | - Juliette Hukin
- Neurology-Oncology, British Columbia Children's Hospital, 4480 Oak Street, Room B315, Vancouver, BC, V6H 3V4, Canada
| | - Cynthia Hawkins
- Pediatric Laboratory Medicine, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
| | - Nada Jabado
- Pediatrics, The Montreal Children's Hospital of the MUHC, 4060 Ste Catherine West, Montreal, QC, H3Z 2Z3, Canada
| | - Donna Johnston
- Hematology Oncology, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada
| | - Tania Brown
- Pediatric Oncology, Saskatoon Cancer Centre, #20 Campus Drive, Saskatoon, SK, S7N 4H4, Canada
| | - Valerie Larouche
- Pediatric Hematology Oncology, Centre Hospitalier de l'Université Laval (CHUL), 2705, boulevard Laurier, Quebec, G1V 4G2, Canada
| | - Katrin Scheinemann
- Department of Pediatrics, McMaster Children's Hospital, 1280 Main Street West, Hamilton, ON, L8S 4K1, Canada
| | - Douglas Strother
- Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, T3B 6A8, Canada
| | - Beverly Wilson
- Pediatric Oncology, Stollery Children's Hospital, Aberhart Centre One, 11402 University Ave, Edmonton, AB, T6G 1C9, Canada
| | - Shayna Zelcer
- Pediatrics, London Children's Hospital, 800 Commissioner's Road East, London, ON, N6C 2V5, Canada
| | - Annie Huang
- Pediatric Brain Tumor Program, Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1XB, Canada
| | - Eric Bouffet
- Pediatric Brain Tumor Program, Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1XB, Canada
| | - Lucie Lafay-Cousin
- Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, T3B 6A8, Canada.
| |
Collapse
|
3
|
Negahban S, Nagel I, Soleimanpour H, Aledavood A, Bagheri N, Paydar M, Daneshbod K, Hasselblatt M, Gesk S, Siebert R, Daneshbod Y. Prenatal Presentation of a Metastasizing Rhabdoid Tumor With Homozygous Deletion of the SMARCB1 Gene. J Clin Oncol 2010; 28:e688-91. [DOI: 10.1200/jco.2010.29.9735] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Shahrzad Negahban
- Institute of Pathology, Dr Daneshbod Pathology Laboratory, Shiraz, Iran
| | - Inga Nagel
- Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany
| | | | - Azita Aledavood
- Institute of Pathology, Dr Daneshbod Pathology Laboratory, Shiraz, Iran
| | - Neda Bagheri
- Institute of Pathology, Dr Daneshbod Pathology Laboratory, Shiraz, Iran
| | - Mehdi Paydar
- Institute of Obstetrics and Fetal Medicine, Shiraz, Iran
| | - Khosrow Daneshbod
- Institute of Pathology, Dr Daneshbod Pathology Laboratory, Shiraz, Iran
| | - Martin Hasselblatt
- Institute of Neuropathology, University Hospital Münster, Münster, Germany
| | - Stefan Gesk
- Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany
| | - Reiner Siebert
- Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany
| | - Yahya Daneshbod
- Institute of Pathology, Dr Daneshbod Pathology Laboratory, Shiraz, Iran
| |
Collapse
|
4
|
Han L, Qiu Y, Xie C, Zhang J, Lv X, Xiong W, Wang W, Zhang X, Wu P. Atypical teratoid/rhabdoid tumors in adult patients: CT and MR imaging features. AJNR Am J Neuroradiol 2010; 32:103-8. [PMID: 21051520 DOI: 10.3174/ajnr.a2361] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Primary AT/RT is a rare highly malignant tumor of the CNS, usually occurring in children younger than 5 years of age. The objective of this study was to characterize the CT and MR imaging findings in a series of 5 adult patients with pathologically proved AT/RT. All 5 AT/RTs were supratentorial. In 2 patients who underwent nonenhanced CT, the tumors appeared isoattenuated, and 1 of the 2 tumors contained calcifications. Solid portions of the tumors on MR imaging were isointense on T1-weighted, T2-weighted, and FLAIR images, and 1 case showed restricted diffusion on DWI. The tumors also demonstrated a bandlike rim of strong enhancement surrounding a central cystic area on contrast-enhanced T1-weighted imaging. One tumor was associated with destruction of the calvaria. Although AT/RTs can have nonspecific findings, the tumors in our series were large and isointense on T1-weighted, T2-weighted, and FLAIR images with central necrosis and prominent rim enhancement.
Collapse
Affiliation(s)
- L Han
- Department of Medical Imaging and Interventional Radiology, Cancer Center, Sun Yat-Sen University, Guangzhou, PR China
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Isaacs H. Fetal and neonatal rhabdoid tumor. J Pediatr Surg 2010; 45:619-26. [PMID: 20223330 DOI: 10.1016/j.jpedsurg.2009.12.011] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2009] [Revised: 12/14/2009] [Accepted: 12/14/2009] [Indexed: 12/21/2022]
Abstract
PURPOSE Few studies have focused on the behavior of rhabdoid tumor (RT) in the fetus and neonate. The purpose of this review is to show that perinatal RTs are associated with unusual findings and a poor prognosis. METHODS The author conducted a 40-year systematic review of the literature. Clinical presentation, pathology, management, and outcome of 72 fetuses and neonates with RTs are discussed. RESULTS Seventy-two fetuses and neonates presented with RTs detected prenatally (n = 12) and during the neonatal period (n = 60). The review consisted of 3 main groups: extrarenal noncentral nervous system (CNS) RT, renal RT, and CNS RT. There were some group differences in survival: extrarenal non-CNS RT (3/33 or 9.1%), renal RT (2/27 or 7.4%), and CNS RT (2/12 or 16.7%). Metastatic RT was present at diagnosis in more than half the patients (41/72 or 57%) who had a survival of 2.3%. The overall survival was 9.7%. For statistical results, there was no significant difference in survival among the 3 groups by type of tumor (P = .692). chi(2) analysis for survival with and without metastases was not valid due to small sample size. CONCLUSIONS The review shows that extrarenal RT was more common than either renal RT or CNS RT groups that is different than that observed in older individuals. Concomitant brain tumors were found in almost a third of fetuses and neonates. The CNS involvement occurred more often in patients with renal RT than in those with extrarenal RT. Metastatic disease at diagnosis was noted in more than half of the patients. Higher stage and presence of a CNS tumor were significant determinants in survival.
Collapse
Affiliation(s)
- Hart Isaacs
- Department of Pathology, Rady Children's Hospital San Diego, San Diego, CA 92123, USA.
| |
Collapse
|
6
|
Vazquez E, Castellote A, Mayolas N, Carreras E, Peiro JL, Enríquez G. Congenital tumours involving the head, neck and central nervous system. Pediatr Radiol 2009; 39:1158-72. [PMID: 19774372 DOI: 10.1007/s00247-009-1369-4] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2008] [Revised: 05/15/2009] [Accepted: 07/01/2009] [Indexed: 10/20/2022]
Abstract
Congenital intracranial tumours are uncommon and differ from those occurring in older children in clinical presentation, imaging characteristics and prognosis. These tumours are often detected incidentally on routine prenatal US and/or fetal MRI. Hence, the paediatric radiologist should be familiar with the features of those lesions that should be included in the differential diagnosis. In general, the prognosis of these conditions is poor owing to large tumour size and the limitations of adjuvant therapy at such a young age. Congenital lesions involving the head and neck region require a meticulous imaging approach using both US and MRI techniques to better guide prenatal planning and fetal or neonatal surgical procedures.
Collapse
Affiliation(s)
- Elida Vazquez
- Department of Pediatric Radiology, Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain.
| | | | | | | | | | | |
Collapse
|